Lunit Inc. (KOSDAQ:328130)
South Korea · Delayed Price · Currency is KRW 8,300.00
+90.00 (1.10%)
Sep 17, 2026, 3:30 PM KST
Lunit Market Cap
Lunit has a market cap or net worth of 611.3 billion as of September 16, 2026. Its market cap has decreased by -51.99% in one year.
Market Cap
611.30B
Enterprise Value
521.15B
Revenue
91.82B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,300.00
ChartMarket Cap Chart
Since July 21, 2022, Lunit's market cap has increased from 420.31B to 611.30B, an increase of 45.44%. That is a compound annual growth rate of 9.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 611.30B | -49.16% |
| Dec 30, 2025 | 1.20T | -34.88% |
| Dec 30, 2024 | 1.85T | -20.82% |
| Dec 28, 2023 | 2.33T | 540.04% |
| Dec 29, 2022 | 364.38B | -13.31% |
| Jul 21, 2022 | 420.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 65.66T |
| Celltrion | 42.60T |
| ALTEOGEN | 18.10T |
| Samsung Epis Holdings | 8.27T |
| Komipharm International | 669.89B |
| Onconic Therapeutics | 664.32B |
| Pharmicell | 651.64B |
| Myung In Pharmaceutical LTD. | 633.64B |